BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2767117)

  • 1. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
    Kennett GA; Whitton P; Shah K; Curzon G
    Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
    Jenck F; Broekkamp CL; Van Delft AM
    Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.
    Kennett GA
    Psychopharmacology (Berl); 1992; 107(2-3):379-84. PubMed ID: 1352056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT1C-receptors in drug-induced penile erections in rats.
    Berendsen HH; Jenck F; Broekkamp CL
    Psychopharmacology (Berl); 1990; 101(1):57-61. PubMed ID: 2343074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the isolation-induced social behavioural deficit involves activation of the 5-HT1B receptors.
    Frances H; Lienard C; Fermanian J
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):91-102. PubMed ID: 2300682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP.
    Durand M; Mormède P; Chaouloff F
    Behav Pharmacol; 2003 Mar; 14(2):173-7. PubMed ID: 12658079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats.
    Kitchener SJ; Dourish CT
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):369-77. PubMed ID: 7862847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.
    Curzon G
    Adv Exp Med Biol; 1991; 294():377-88. PubMed ID: 1837683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia.
    Kennett GA; Curzon G
    Br J Pharmacol; 1991 Aug; 103(4):2016-20. PubMed ID: 1912990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
    Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mCPP-induced anxiety in the light-dark box in rats--a new method for screening anxiolytic activity.
    Bilkei-Gorzó A; Gyertyán I; Lévay G
    Psychopharmacology (Berl); 1998 Apr; 136(3):291-8. PubMed ID: 9566815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.